IL2RB and breast carcinoma: In addition, AKT3 was targeted by miR-29 in breast cancer, and cytokine receptor (IL2RB and IL6R) and one component of the PI3K complex (PIK3R3) were also targeted by miR-34a and miR-29, respectively, in DLBCL.